Carisma Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CARM and other ETFs, options, and stocks.

About CARM

Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. 

CEO
Steven Kelly
CEOSteven Kelly
Employees
46
Employees46
Headquarters
Philadelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded
2016
Founded2016
Employees
46
Employees46

CARM Key Statistics

Market cap
7.25M
Market cap7.25M
Price-Earnings ratio
-0.15
Price-Earnings ratio-0.15
Dividend yield
—
Dividend yield—
Average volume
1.24M
Average volume1.24M
High today
$0.21
High today$0.21
Low today
$0.1626
Low today$0.1626
Open price
$0.2019
Open price$0.2019
Volume
6.06M
Volume6.06M
52 Week high
$1.90
52 Week high$1.90
52 Week low
$0.1601
52 Week low$0.1601

People also own

Based on the portfolios of people who own CARM. This list is generated using Robinhood data, and it’s not a recommendation.
SNDL
NIO
Cenntro Inc.
Lucid Group
Workhorse
Tilray Brands
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.